Clincosm LogoSign in Get a demo

SCREENING: Prevalence of DVT or PE in Patients Infected With COVID-19 Admitted to Hospital

Sponsor
Manuel Monreal (Other)
Overall Status
Completed
CT.gov ID
NCT04380792
Collaborator
(none)
2,497
Enrollment
1
Location
6
Actual Duration (Months)
415.3
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The main objectives are:

  • To establish the prevalence of deep venous thrombosis through ultrasonography in Patients infected with COVID-19 admitted to hospital.

  • To identify patients with higher risk of deep venous thrombosis.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    2497 participants
    Observational Model:
    Other
    Time Perspective:
    Retrospective
    Official Title:
    Prevalence of DVT or PE in Patients Infected With COVID-19 Admitted to Hospital (SCREENING Study)
    Actual Study Start Date :
    Apr 13, 2020
    Actual Primary Completion Date :
    Oct 13, 2020
    Actual Study Completion Date :
    Oct 13, 2020

    Outcome Measures

    Primary Outcome Measures

    1. VTE events and complications [30 days]

      Study endpoints are clinically recognized (and objectively confirmed) recurrences of VTE, major and minor bleeding complications, and death.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    • Patients infected with COVID-19.

    • Admission to hospital.

    Exclusion Criteria:
    • Patients treated with ECMO (Extracorporeal membrane oxygenation).

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Manuel Monreal Badalona Barcelona Spain 08916

    Sponsors and Collaborators

    • Manuel Monreal

    Investigators

    • Study Chair: Manuel Monreal, Germans Trias i Pujol Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Manuel Monreal, Professor of Internal Medicine, Foundation for the study of VTE diseases. (FUENTE)
    ClinicalTrials.gov Identifier:
    NCT04380792
    Other Study ID Numbers:
    • SCREENING042020
    First Posted:
    May 8, 2020
    Last Update Posted:
    Dec 14, 2020
    Last Verified:
    Dec 1, 2020
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:
    COVID-19

    Study Results

    No Results Posted as of Dec 14, 2020